Advertisements



We are Sorry, This Page doesn't Exist


Immunic announces results of interim dosing analysis for CALDOSE-1 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 5th, 2019

Array BioPharma announces interim analysis results from BEACON CRC trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 7th, 2019

AstraZeneca announces results from interim analysis of Phase 2 ASCEND trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 16th, 2019

Immunic announces interim data from Cohort 2 of EMPhASIS trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 15th, 2021

Translate Bio announces results from second interim analysis of MRT5005 doses

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 17th, 2021

Puma Biotechnology announces interim results from SUMMIT trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 15th, 2021

Krystal Biotech announces interim results from Phase 1/2 trial of KB105

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 14th, 2020

Harborside Inc. Announces Preliminary Fiscal 2019 and First Quarter 2020 Results and Advises on Timing of Filing Annual Financial Statements and Management"s Discussion and Analysis

-       Preliminary Fiscal 2019 Results Consistent with Previously Announced Full Year Guidance-       Strong Start to Fiscal 2020 Based on Preliminary First Quarter 2020 Interim Results-       Earnings for F.....»»

Category: earningsSource: benzingaApr 23rd, 2020

AnaptysBio Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Pipeline Updates

Interim Top-Line Data From Etokimab ECLIPSE Phase 2 Trial in Chronic Rhinosinusitis with Nasal Polyps Anticipated in First Half of 2020    Reported Positive Topline Data .....»»

Category: earningsSource: benzingaMar 2nd, 2020

resTORbio announces interim results for Phase 1b/2a trial of RTB101

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 19th, 2020

Eli Lilly announces ORIENT-11 trial met primary endpoint in interim analysis

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 13th, 2020

aTyr Pharma announces interim safety results from Phase 1b/2a trial of ATYR1923

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 12th, 2019

Tonix Pharmaceuticals Reports Third Quarter 2019 Financial Results and Operational Highlights

50% of Enrollment Complete for Phase 3 RECOVERY Trial of Tonmya® for the Treatment of PTSD Results from RECOVERY Interim Analysis Expected First Quarter 2020 Topline Data Expected Second Quarter 2020 Based on Cu.....»»

Category: earningsSource: benzingaNov 8th, 2019

Auris Medical announces interim results from Phase 1b trial with AM-201

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2019

Kiniksa announces interim results from Phase 1b KPL-716 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 12th, 2019

DiaMedica Therapeutics announces interim results for DM199 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 19th, 2019

J&J announces results of new analysis from CREDENCE trial of Invokana

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 11th, 2019

La Jolla announces results from interim analysis of Phase 2 study of LJPC-401

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 6th, 2019

Rubicon Minerals Announces the Filing of its First Quarter 2019 Results

TSX: RMX | OTCQX: RBYCF TORONTO, May 8, 2019 /CNW/ - Rubicon Minerals Corporation (TSX:RMX, OTCQX:RBYCF) ("Rubicon" or the "Company") announces that it has filed its interim Financial Statements and Management's Discussion and Analysis ("MD&A").....»»

Category: earningsSource: benzingaMay 8th, 2019

Novocure announces STELLAR phase 2 trial exceed interim analysis

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 17th, 2018